Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stevanato Group SpASTU:87N 88 5-Year Yield-on-Cost % is 0.31 as of Sep. 09, 2026, which is 15% above its 10-year median of 0.27. GuruFocus rates STU:87N with a GF Score™ of 88/100 and a GF Value™ of €22.17 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 314 Medical Devices & Instruments companies, Stevanato Group SpA ranks worse than 93.31% on this metric.
Stevanato Group SpA's yield on cost for the quarter that ended in Jun. 2026 was 0.31.
The historical rank and industry rank for Stevanato Group SpA's 5-Year Yield-on-Cost % or its related term are showing as below:
STU:87N'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.17 Med: 0.27 Max: 0.46
Current: 0.31
During the past 8 years, Stevanato Group SpA's highest Yield on Cost was 0.46. The lowest was 0.17. And the median was 0.27.
STU:87N's 5-Year Yield-on-Cost % is ranked worse than 93.31% of 314
companies
in the Medical Devices & Instruments industry
Industry Median: 2.475
vs STU:87N: 0.31
Stevanato Group SpA (STU:87N) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Stevanato Group SpA 5-Year Yield-on-Cost % Related Terms
STU:87N vs MMED, TFX, MMSI: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stevanato Group SpA 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Stevanato Group SpA's 5-Year Yield-on-Cost % falls into.
Stevanato Group SpA 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Stevanato Group SpA (STU:87N) has a 5-Year Yield-on-Cost % of 0.31 as of Sep. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Stevanato Group SpA and its competitors. This is 15% above median its historical median of 0.27. Over the past decade, Stevanato Group SpA's 5-Year Yield-on-Cost % has ranged from 0.17 to 0.46. According to the industry distribution chart, Stevanato Group SpA ranks #293 out of 314 companies in the Medical Devices & Instruments industry, placing it in the top 93.3%.
Is Stevanato Group SpA's 5-Year Yield-on-Cost % too high?
Stevanato Group SpA's current 5-Year Yield-on-Cost % of 0.31 is 15% above median its 10-year median of 0.27. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 0.46. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.48. Stevanato Group SpA's value of 0.31 is 87.5% below this industry median. Based on the distribution chart, Stevanato Group SpA ranks #293 out of 314 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Stevanato Group SpA has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stevanato Group SpA's 5-Year Yield-on-Cost % compare to MMED and TFX?
According to the Medical Devices & Instruments industry distribution chart, Stevanato Group SpA ranks #293 out of 314 companies for 5-Year Yield-on-Cost %. This places Stevanato Group SpA in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.48. Stevanato Group SpA's value of 0.31 is 87.5% below this benchmark. Historically, Stevanato Group SpA's own 5-Year Yield-on-Cost % has ranged from 0.17 to 0.46 over the past decade. While the company's 10-year median is 0.27 vs. the industry median of 2.48, Stevanato Group SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.48, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stevanato Group SpA's current 5-Year Yield-on-Cost % of 0.31 is 87.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Stevanato Group SpA and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stevanato Group SpA's current 5-Year Yield-on-Cost % is 0.31, which is 15% above median its own 10-year median of 0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stevanato Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Stevanato Group SpA (STU:87N) is currently considered Modestly Undervalued. The stock's GF Value™ is €22.17, compared to a current price of €17.30 — trading 22% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.31, which is 15% above median its 10-year median of 0.27 and 87.5% below the Medical Devices & Instruments industry median of 2.48. Stevanato Group SpA's overall GF Score™ is 88/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Stevanato Group SpA (STU:87N), the current 5-Year Yield-on-Cost % is 0.31 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stevanato Group SpA (STU:87N) Overvalued in 2026?
Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued.
The current stock price of €17.30 is trading 22% below its estimated GF Value™ of €22.17.
GuruFocus considers Stevanato Group SpA to be Modestly Undervalued.
Key valuation signals for STU:87N:
5-Year Yield-on-Cost %: 0.31 (15% above median its 10-year median of 0.27)
GF Value™: €22.17 vs. price of €17.30 (22% below fair value)
Industry Position: 87.5% below the Medical Devices & Instruments median (#293 of 314)
No single metric tells the full story. See the STU:87N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
88GF Score
Get the complete analysis for STU:87N
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:87N has been successfully added to your 
